Companies Dominating the Enzyme-linked Immunosorbent Assay Landscape
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Neogen Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers AG
- BD (Becton, Dickinson and Company)
- Agilent Technologies, Inc.
- BioMérieux SA
- Ortho Clinical Diagnostics
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Enzyme-linked Immunosorbent Assay Market in 2025 is assessed at USD 13.29 billion.
The global market size was worth more than USD 12.64 billion in 2024 and is poised to witness a CAGR of more than 6.4%, crossing USD 28.31 billion revenue by 2037.
North America is anticipated to garner USD 9.91 billion by 2037, fueled by rise in chronic diseases and the demand for advanced diagnostic tools like ELISA.
The major players in the market include Thermo Fisher Scientific Inc., Neogen Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, BD (Becton, Dickinson and Company), Agilent Technologies, Inc., BioMérieux SA, Ortho Clinical Diagnostics.
